Blueprint Medicines Corp (BPMC)

Blueprint Medicines Corp. is a precision therapy company, which engages in the invention of medicines for people with cancer and blood disorders. The company was founded by Chris Varma, Nicholas B. Lydon, Brian Druker, and Alexis Borisy on October 14, 2008 and is headquartered in Cambridge, MA.

Address

45 SIDNEY STREET
CAMBRIDGE, MA 02139

Founded

2008

Number of Employees

655

Buyback

Buyback Data 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 Average
$ Amount Purchased
($ in 000s)
- $26 - - - - - - - - - $26
Average Price - $1.05 - - - - - - - - - $1.05
# Shares Purchased - 24,227 - - - - - - - - - 24,227
Buyback Performance 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 Average
Total Return to Date - 8,916.0% - - - - - - - - - 8,916.0%
S&P 500 Return to Date - 174.1% - - - - - - - - - 174.1%
Excess Total Return - 8,741.9% - - - - - - - - - 8,741.9%
Quartile Rank
Percentile Rank - 100% - - - - - - - - - 100%
Buyback returns calculated using weighted average buyback price over the last 10 years and comparing to current day stock price value. S&P 500 used as benchmark for excess return.
Filters

Keyboard Shortcuts: Show (a) | Close (Esc)